Orthovita to Present at the Piper Jaffray 22nd Annual Health Care Conference
MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it will present at the Piper Jaffray 22nd Annual Health Care Conference in New York. Antony Koblish, President and Chief Executive Officer of Orthovita, is scheduled to present on Tuesday, November 30, 2010, at 8:00 a.m. Eastern Time, at The New York Palace Hotel, 455 Madison Avenue, New York, NY 10022. A live audio webcast of the presentation will be available, and can b
View full post on All Stories
Saints hope bye brings health and consistency
The defending champion New Orleans Saints have demonstrated that they can defend with the best in the NFL this season.
View full post on All Stories
Midterm Voters Didn’t View Health Care Law As Priority
The economy was voters’ top concern but of those who put health care at the top, 56% wanted repeal. But among Democrats and those who didn’t vote, the health care law was popular.
View full post on All Stories
R.I. to get $1.9 million in Glaxo drugs settlement
By Thomas J. Morgan
PROVIDENCE, R.I. — Attorney General Patrick C. Lynch on Friday announced that Rhode Island will receive nearly $2 million in state and federal money in a settlement with GlaxoSmithKline of allegations that the pharmaceutical manufacturer introduced adulterated drugs into interstate commerce.
Lynch said in a news release that the company is paying the states and the federal government $600 million in civil damages and penalties for Medicaid and other federally funded health care programs.
Rhode Island’s share of the settlement is $1,949,563.70. As part of that, the state will get $588,852 that Lynch’s office will forward to the Rhode Island Department of Human Services, which administers Medicaid, the joint state-federal health insurance program for low-income Americans. The balance of the recovered money allocated to Rhode Island represents the federal portion of the Medicaid recovery, and will go to the US Department of Health and Human Services.
According to Lynch’s news release, the settlement grew out of an action filed in 2004 in U.S. District Court in Massachusetts. A whistleblower’s complaint alleged that the company knowingly manufactured, distributed and sold four products — Paxil CR, Avandamet, Kytril and Bactroban — whose strength, purity and/or quality fell below the standards required by the FDA.
Continue reading…
View full post on All Stories
New drug may provide more cost-effective stroke prevention than warfarin
A newly approved drug may be a cost-effective way to prevent stroke in patients with an irregular heart rhythm – and may also offer patients better health outcomes than the commonly prescribed, but potentially risky, blood thinner warfarin. That’s according to a new analysis from researchers at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System.
View full post on All Stories
HHS to Announce Resources for States to Design IT Systems for Health Insurance Exchanges
WASHINGTON–(BUSINESS WIRE)–On Friday, October 29, at 12:00 p.m. (EDT) Jay Angoff, director of the Office of Consumer Information and Insurance Oversight (OCIIO) and Joel Ario, director of health insurance exchanges within OCIIO, will hold a press conference call to discuss exciting new Affordable Care Act resources for states to design and implement the information technology (IT) infrastructure needed to operate health insurance exchanges. WHO: Jay Angoff, Director of the Office of Consumer
View full post on All Stories
Women ‘miss father health clues’
Women at risk of breast cancer miss out on tests because a history of the disease in their father’s family is disregarded, suggests a study.
View full post on All Stories
ABB shooting victim’s father now has insurance coverage approval
ABB shooting victim’s father now has insurance coverage approval
View full post on All Stories
Dr Reddys gets US FDA approval for Lansoprazole
Dr Reddy’s Laboratories on Saturday said it has received an approval from the US health regulator to sell a generic version of Takeda Pharmaceuticals ‘Prevacid delayed release capsules’ in the US market.
View full post on All Stories
Supreme Court weighs lawsuits over vaccine, autism
The Supreme Court is trying to sort out whether drug companies can be sued for claims of serious side effects from childhood vaccines without driving vaccine makers from the market and risking a public health crisis.
View full post on All Stories
Loans- U.S. expands faster airport screening process to busiest airports
- Airbus A380 wings to have checks for cracks
- Talks continue between MTA, New York transit workers
- China opposes EU scheme on carbon tax for airlines flying in Europe
- FAA to issue rules on pilot fatigue more than a year after deadline
- FAA to issue rules on pilot fatigue more than a year after deadline
- Boeing machinists accept 4 year contract extension
- Women-only taxis start plying on Malaysian roads
- Urgent drive to act on road safety in Africa
- U.S. officials worried about exploding shipping containers from Vietnam
- Loans
- Sarah Burton wins Designer of the Year at 2011 British Fashion Awards
- Gaudy Christmas sweaters making fashion comeback
- Latest Discounts
- Givenchy Handbags Sale
- 20% Off at GoJane Coupon Ends in 4 Days!
- Shopbob Major Mid Season Sales 30% to 70% Off
- Barbie gets inked in fashion makeover
- Sales 50% Off from Three Dots Detail
- Start A Fashion Business (Quick Guide)
- 7 for All Mankind Sales from Couture Candy
- Loans
- Crocs footwear moves into accessories and apparel
- Hottest 2012 Super Bowl souvenir is a hand-knit scarf
- Digital catwalk is the new fashion for couture shows
- Over-the-top sneakers are everywhere
- Let the returns and exchanges begin
- Hats that won’t leave you with helmet head
- Auctions sell Elizabeth Taylor’s jewels, Steve Jobs’ Apple contract for millions
- Keep your cashmere in shape for seasons to come
- Barneys devotes whole floor to world of Gaga
- Intimacy 2.0 dress becomes transparent as you flirt
